[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592096":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":40,"locations":48,"responsibleParty":67,"collaborators":26,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":26,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":26,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":91,"overallStatus":51,"whyStopped":26,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Zagazig University","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group ILE (Intravenous lipid emulsion group)","EXPERIMENTAL","patients will receive 1.5 ml\u002Fkg bolus of intravenous lipid emulsion 20 % followed by 0.25 ml\u002Fkg\u002Fhour infusion over 30 minutes at the end of surgery",[13],"Drug: Intravenous Lipid Emulsion 20%",{"label":15,"type":16,"description":17,"interventionNames":18},"Group C (control group)","PLACEBO_COMPARATOR","patients will received equal volume of normal saline at the end of surgery",[19],"Drug: Control (placebo) group",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Intravenous Lipid Emulsion 20%","patients will receive 1.5 ml\u002Fkg bolus of intravenous lipid emulsion 20 % followed by 0.25 ml\u002Fkg\u002Fhr infusion over 30 minutes at the end of surgery",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Control (placebo) group","patients will receive equal volume of normal saline at the end of surgery",[15],[32,36],{"name":33,"affiliation":34,"role":35},"Sherif M. S. Mowafy, MD","Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University,","PRINCIPAL_INVESTIGATOR",{"name":37,"affiliation":38,"role":39},"Shereen E. Abd Ellatif, MD","Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University","STUDY_DIRECTOR",[41,45],{"name":33,"role":42,"phone":43,"phoneExt":26,"email":44},"CONTACT","+201003523374","sherifmowafy2012@gmail.com",{"name":37,"role":42,"phone":46,"phoneExt":26,"email":47},"+201007948840","shosh.again@gmail.com",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Zagazig University Hospitals","RECRUITING","Zagazig","Al Sharqia","44519","Egypt","EG",{"type":58,"coordinates":59},"Point",[60,61],31.502,30.58768,{"lat":61,"lon":60},[64,65,66],{"name":33,"role":42,"phone":43,"phoneExt":26,"email":44},{"name":37,"role":42,"phone":46,"phoneExt":26,"email":47},{"name":37,"role":35,"phone":26,"phoneExt":26,"email":26},{"type":35,"investigatorFullName":68,"investigatorTitle":69,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Sherif M. S. Mowafy","Associate professor of anesthesia, intensive care, and pain management","100592096","lipid-emulsion-for-reversal-of-spinal-anesthesia-in-ambulatory-surgery-100592096",false,"NCT06988982","Lipid Emulsion for Reversal of Spinal Anesthesia in Ambulatory Surgery","Lipid Emulsion for Reversal of Spinal Anesthesia in Ambulatory Surgery: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patient acceptance.\n* Cooperative patient\n* Age 21-70 years old.\n* BMI ≤ 35 kg\u002Fm2\n* ASA I - II.\n* Elective ambulatory surgery under spinal anesthesia (general surgery, urology, gynecology, orthopedic surgery).\n\nExclusion Criteria:\n\n* History of allergy to the LA agents used in this study,\n* Skin lesion at needle insertion site,\n* Those with bleeding disorders, sepsis, liver disease and psychiatric disorders\n* History of cognitive dysfunction or mental illness","ALL","21 Years","70 Years",{"count":81,"type":82},42,"ESTIMATED","INTERVENTIONAL",[85],"NA","Ambulatory surgery places high demands on anesthetic technique. rapid onset and offset of anesthesia, rapid recovery of protective reflexes, mobility and micturition, are required. Since the inception of ambulatory surgery, the favored anesthetic technique has been general anesthesia with short-acting drugs. Concerns about the time to perform spinal anesthesia and the risks of prolonged motor block and urinary retention have limited its use.\n\nAlpha-blockers, lavage fluids for epidural space, insulin, and intravenous lipid emulsions, are still being discussed to shorten and reverse adverse effect of different LAs used for spinal anaesthesia, hence we will evaluate the effectiveness of intravenous lipid emulsion for reversing the neural blockade of spinal anaesthesia in patients undergoing ambulatory surgery.",[88,89,90],"Spinal Anaesthesia","Spinal Anesthesia Evaluation","Ambulatory Surgery",[92,93,94],"lipid emulsion","spinal anesthesia","ambulatory surgery","2025-05-17",{"date":97,"type":98},"2025-05-25","ACTUAL",{"date":100,"type":82},"2025-06-01",{"date":102,"type":82},"2026-01-01",{"name":5,"class":6},1]